2016-02-26 05:14:27 – Biological Hazard – USA


RSOE EDIS ALERTMAIL
RSOE Emergency and Disaster Information Service
Budapest, Hungary
2016-02-26 05:14:27 – Biological Hazard – USA
EDIS Code: BH-20160226-52242-USA
Date&Time: 2016-02-26 05:14:27 [UTC]
Continent: North-America
Country: USA
State/Prov.: State of New Jersey,
Location: Shore Medical Center,
City: Somers Point
Number of infected people: 200
More than 200 people treated at a New Jersey medical center may have been exposed to HIV or hepatitis B or C because of a former employee accused of tampering with drugs, the hospital said on Thursday. Shore Medical Center in Somers Point, located on the southern New Jersey coast outside of Atlantic City, sent letters last week to 213 patients who were treated with certain intravenous medications, including morphine, between June 1, 2013 and Sept. 17, 2014. “We have been working with public health authorities to determine if patients could have been exposed to blood-borne pathogens at Shore through contact with this employee’s blood,” said hospital spokesman Brian Cahill in a statement. Free testing and support are being offered to the patients, the hospital said. New Jersey Health Department spokeswoman Dawn Thomas described the risk of exposure as low. Frederick McLeish, 53, a former pharmacist at the hospital, is accused of removing the drugs from vials intended to be used in the preparation of intravenous medications for patients, and replacing them with a saline solution. His attorney, John Zarych, declined to comment on the case. The hospital detected a problem and fired McLeish, of Egg Harbor Township, after an internal investigation. On Jan. 21 he was indicted by an Atlantic County grand jury on charges of drug tampering, theft and drug possession. He was released on bail the same day, according to a court official. On Monday, McLeish was arraigned in Atlantic County Superior Court. A status hearing, at which he is expected to enter a plea, has been scheduled for March 7. McLeish had been authorized to prescribe, dispense or administer medication, according to the Atlantic County prosecutor’s office. The hospital, state health department and Centers for Disease Control and Prevention are still investigating.
The name of Hazard: HIV or hepatitis B or C infection
Species: Human
Status: Confirmed
Posted:2016-02-26 05:14:27 [UTC]

How Would CDC Know That 3.2 million Americans Have Hepatitis C, That Were Born Between 1945 and 1965? Unless They Gave It To Them…


Email Received from CDC:

Viral Hepatitis Updates from CDC

CDC Releases New Phase of the Know More Hepatitis Campaign
Of the estimated 3.2 million Americans who have Hepatitis C, 3 in 4 are people born from 1945 to 1965. The Know More Hepatitis campaign encourages everyone born from 1945-1965 to follow the CDC recommendation to get tested for Hepatitis C.

The campaign is being implemented using a variety of multi-media channels including print, radio and TV PSAs, as well as airport dioramas, billboards, and transit advertisements. CDC developed additional campaign materials to help educate patients and promote testing for Hepatitis C including a new video PSA “Hepatitis C: A Hidden Disease”which shows that even if you have a healthy life and no symptoms, you could still have Hepatitis C.

Implementing the Viral Hepatitis Action Plan: The Role of Community Leadership
Since the release of the 2014 Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis, groups like Hep B United (HBU) have used it as a framework to help guide their work. HBU utilized the Stakeholders’ Workbook as a starting point to develop a Strategic Plan which highlights HBU members’ areas of focus: community and provider education, improving testing and linkage to care to prevent hepatitis B-related liver disease and cancer, eliminating perinatal transmission of hepatitis B, and strengthening hepatitis B and C surveillance efforts. HBU also developed Opportunities for Federal-Community Collaboration to Reduce Disparities in Hepatitis B: 2014-2016 which highlights ways in which HBU members can collaborate in larger federal inter-agency efforts. https://blog.aids.gov/2015/01/implementing-the-viral-hepatitis-action-plan-the-role-of-community-leadership.html

NIH Announces Funding for New Technologies for Viral Hepatitis
The National Institutes of Health (NIH) has issued a funding opportunity announcement (FOA). A Small Business Innovation Research (SBIR) grant entitled New Technologies for Viral Hepatitis SBIR (R43/R44) encourages small businesses to address viral hepatitis research opportunities delineated in the Action Plan including (but not limited to) the development of: rapid screening tests, new diagnostic tests, tests for viral hepatitis-related complications, practical models of care, new and improved therapies to treat viral hepatitis or manage complications of disease or antiviral treatment, genetic-based tests for patient management or treatment selection, preventive vaccines, innovative approaches to pathogen identification and reduction in blood products. https://blog.aids.gov/2015/01/nih-announces-funding-for-new-technologies-for-viral-hepatitis.html